Northleaf Completes Investment in CCM Hockey alongside Altor Equity Partners
Northleaf Capital Partners (“Northleaf”), a global private markets investment firm, today announced that funds under its management have completed an investment in CCM Hockey (“CCM” or “the Company”). Northleaf partnered with Altor Equity Partners (“Altor”), a leading European middle-market private equity firm, to acquire the business. Financial terms of the transaction were not disclosed.
Founded in 1899, CCM is a leading designer, manufacturer, and distributor of hockey equipment, including sticks, skates, protective gear, helmets, goalie equipment, and apparel. Headquartered in Montreal, Canada, the Company operates in more than 40 countries and is represented by many NHL and PWHL superstars.
“Northleaf is proud to be a part of Canadian hockey history and support CCM’s next stage of growth, alongside a trusted mid-market sponsor like Altor,” said Michael Flood, Head of Private Equity at Northleaf. “CCM’s iconic brand and strong industry tailwinds, coupled with Altor’s deep consumer experience, create a very attractive opportunity to generate strong risk-adjusted returns for our investors.”
“Northleaf is an experienced investor with a global network and deep knowledge in the local Canadian market and we’re excited to be partnering with their team,” said Andreas Källström Säfweräng, Partner and Head of the Consumer Sector at Altor. “Together, our resources and expertise will allow CCM to accelerate its strategic initiatives and unlock new growth opportunities.”
“This is an exciting new chapter to mark CCM’s 125-year anniversary,” said Marrouane Nabih, CEO at CCM Hockey. “Northleaf and Altor’s partnership will enable us to scale our ambitious growth strategy and pursue new opportunities across CCM’s global portfolio. Our collective commitment to grow the game of hockey and our passion for product innovation and engagement to providing high-performance and quality products to our consumers makes this a compelling partnership.”
For over 20 years, Northleaf has built a reputation as an established global private markets investor and trusted partner to mid-market companies and private equity sponsors. With a proven track record, strong underwriting capabilities, and a deep understanding of private equity investing, including co-investments, secondaries, structured capital, and primary investments, Northleaf is recognized as a partner of choice. Northleaf has completed more than 150 private equity co-investments, and our investment in CCM further demonstrates the firm’s ability to invest alongside leading private equity sponsors in high-quality mid-market companies.
About Northleaf Capital Partners
Northleaf Capital Partners is a global private markets investment firm with more than US$27 billion in private equity, private credit and infrastructure commitments raised to date from public, corporate and multi-employer pension plans, endowments, foundations, financial institutions and family offices. Northleaf’s 275-person team is located in Toronto, Chicago, London, Los Angeles, Melbourne, Menlo Park, Montreal, New York, Seoul, and Tokyo. Northleaf sources, evaluates and manages private markets investments, with a focus on mid-market companies and assets. For more information on Northleaf, please visit www.northleafcapital.com.
About Altor
Since inception, the family of Altor funds has raised more than EUR 11 billion in total commitments. The funds have invested in just south of 100 companies. The investments have been made in medium-sized predominantly Nordic and DACH companies with the aim to create value through growth initiatives and operational improvements. Among current and past investments are Marshall, Rossignol, Toteme, Helly Hansen, and Revolutionrace.
About CCM
CCM Hockey, a leading designer, manufacturer, and marketer of hockey equipment, and Jackson Ultima, a global leader in figure skate boots, blades and complete skates. With its headquarters located in Montreal, the company has operations in Canada, the United States, Europe and Asia. CCM Hockey equips more professional hockey players than any other company, including NHL and PWHL stars like Auston Matthews, Sidney Crosby, Connor McDavid, Kendall Coyne-Schofield, and Sarah Nurse. CCM Hockey is also an official supplier of the PWHL, and the official outfitter of the American Hockey League, and several NCAA and National teams.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250106264161/en/
Contacts
Media Contacts:
Sneha Satish
Stanton
t: +1.646.502.3556
e: ssatish@stantonprm.com
Gina Lee
Northleaf
Director, Corporate Communications & Corporate Investor Relations
t: +1.416.389.7667
e: gina.lee@northleafcapital.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Making Science Unveils ‘AWAKE’: The AI Venture Studio Industrialising Startup Creation and AI-First Innovative Solutions23.12.2025 20:51:00 CET | Press Release
Making Science, the global digital acceleration consultancy, today announced the launch of AWAKE Venture Studio. This "AI-first" model represents a new era in systematic innovation, designed to identify, prototype, and scale both internal proprietary solutions and independent AI-native startups with global reach. The launch of AWAKE is motivated by the significant efficiency gains of orders of magnitude that Making Science has already achieved through the internal integration of AI. By applying these methods, the firm has achieved a 2x acceleration in tech feature development reducing time in the deployment of AI Agents. This model has already proven its commercial and innovative power through the acceleration of startups like ad-machina, which has multiplied its value by 10 since joining the Making Science ecosystem. These proven benchmarks serve as the technical foundation for AWAKE’s two interconnected engines, which formalise this efficiency into a repeatable manufacturing process
FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia23.12.2025 18:07:00 CET | Press Release
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only Daily Disposable Soft (Hydrophilic) Contact Lens for Presbyopia utilizing patented Extended Depth of Focus (EDOF) optical design technology, enabling commercial distribution in the United States. Deseyne® delivers smooth, continuous focus across near, intermediate, and distance vision, providing clear, natural vision without compromise. This performance is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner. The result is a clear clinical advantage over the only other available contact lens option for presbyopia, multifocal lenses, which rely on multiple optical zones and often require prolonged visual and cognitive adaptation. “We are proud to offer the first contact lens solution for the world’s aging population th
Aramco Awards SLB Long-Term Contract to Support Kingdom’s Unconventional Gas Production Growth23.12.2025 14:58:00 CET | Press Release
Global technology company SLB (NYSE: SLB) has been awarded a five-year contract by Aramco to provide stimulation services for its unconventional gas fields. This award is part of a broader multi-billion contract, supporting one of the largest unconventional gas development programs globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251223074948/en/ The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources. The contract encompasses advanced stimulation, well intervention, frac automation, and digital solutions, which are important to unlocking the potential of Saudi Arabia’s unconventional gas resources — a cornerstone of the Kingdom’s strategy to diversify its energy portfolio and support the global energy transition. “This agreement is an important step forward in Aramco’s effor
Tabelog, Japan's Largest (*1) Restaurant Search and Reservation Service, Launches Multilingual App for International Visitors23.12.2025 14:00:00 CET | Press Release
Tabelog (https://tabelog.com/en/), Japan's largest restaurant search and reservation service operated by Kakaku.com, Inc., launched its multilingual smartphone application (iOS/Android) for international travelers on Monday, November 17, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251221963753/en/ The Tabelog Multilingual App for International Travelers — Japan's Largest Restaurant Search and Reservation Service With approximately 100 million monthly users(*3), Tabelog is Japan's premier service widely used by Japanese locals for daily restaurant discovery. Its database is unrivaled domestically, featuring information on approximately 890,000 establishments nationwide and over 85 million reviews and photos(*4). Unlike global map services or travel sites, Tabelog is built on "authentic ratings and reviews from local Japanese users," enabling travelers to discover truly exceptional restaurants beloved by locals — not
BeOne Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference23.12.2025 12:01:00 CET | Press Release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026, with a presentation at 7:30 am PST. Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com, https://hkexir.beonemedicines.com, https://sseir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company based in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of nearly 12,000 colleagues spanning six continents, the Company is committed to
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom